FDA Approves Expanded Uses for GARDASIL in Preventing Cancer

Tags:
Merck, Gardasil, HPV, Vaginal, Cancer, Vulvar, Cervical, Genitals, Warts, Supplemental, Biologics, License

Add video views to your Facebook Timeline:

September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.

  1. By: NewsInfusion
  2. Categories Science & Tech
  3. Views 299
  4. Added :17-Sep-08
More from the web
Comments on FDA Approves Expanded Uses for GARDASIL in Preventing Cancer
Other comments on this video 0 Comments
 

Up Next: Binary Domain -- Exclusive Multiplayer Trailer